- Lobbying
- Lobbying by Spero Therapeutics, Inc.
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Barrett Thornhill | Legislative Assistant, Sen. Mike Crapo (2003-2006); Legislative Assistant, Rep. Pat Toomey (2002-2003); Legislative Assistant, Rep. Charlie Norwood (2001-2002) |
Paul Dioguardi | Director, Office of Intergovernmental and External Affairs, U.S. Dept. of Health and Human Services (2009-2015); Chief of Staff, Office of Congressional and Intergovernmental Affairs, U.S. Dept. of Labor (1999-2001) |
Libby Greer | Chief of Staff, Rep. Allen Boyd (2001-2009) |
Kristina Dunklin | Legislative Director, Rep. Susan Brooks (2018-2019); Legislative Director, Rep. David Valadao (2015-2018); Legislative Assistant, Rep. David Valadao (2014-2015) |
Derrick White | Deputy Communications Director, Sen. Orrin Hatch (2000-2001) |
Zachary Williams | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q1 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Q4 Report
Lobbying Issues
Agencies Lobbied
U.S. Senate
Type of Issue
Registration
Issue(s) they said they’d lobby about: Issues related to biopharmaceutical research, development and commercialization..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate